Analyst Ratings For CryoPort
Portfolio Pulse from Benzinga Insights
Analyst ratings for CryoPort (NASDAQ:CYRX) show a mix of opinions, with recent actions including ratings adjustments and changes in price targets. The average 12-month price target is now $17.75, up from $17.17. CryoPort faces challenges such as a decline in revenue, below-average net margin, and high debt-to-equity ratio, impacting its financial health. The company operates globally, providing temperature-controlled supply chain solutions to the life sciences industry.
March 15, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CryoPort's mixed analyst ratings and updated price targets reflect varying market perceptions. Financial challenges such as revenue decline and high debt-to-equity ratio could impact investor confidence.
The mixed analyst ratings and the slight increase in the average price target suggest a cautious optimism among analysts, which could lead to a neutral short-term impact on CYRX's stock price. However, the financial challenges highlighted, including a significant revenue decline and a high debt-to-equity ratio, could temper investor enthusiasm, potentially limiting any positive movement in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100